ES8306325A1 - "proceso para la produccion microbiana de interferon fibroblasto humano". - Google Patents

"proceso para la produccion microbiana de interferon fibroblasto humano".

Info

Publication number
ES8306325A1
ES8306325A1 ES515033A ES515033A ES8306325A1 ES 8306325 A1 ES8306325 A1 ES 8306325A1 ES 515033 A ES515033 A ES 515033A ES 515033 A ES515033 A ES 515033A ES 8306325 A1 ES8306325 A1 ES 8306325A1
Authority
ES
Spain
Prior art keywords
human fibroblast
interfered
microbial production
polypeptide
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515033A
Other languages
English (en)
Other versions
ES515033A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8306325(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES515033A0 publication Critical patent/ES515033A0/es
Publication of ES8306325A1 publication Critical patent/ES8306325A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE MICROORGANISMOS CAPACES DE PRODUCIR UN POLIPEPTIDO DEL TIPO QUE COMPRENDE LA SECUENCIA AMINOACIDA DE UN INTERFERON FIBROBLASTO HUMANO. CONSISTE EN TRANSFORMAR UN MICROORGANISMO CON UN VEHICULO DE EXPRESION MICROBIANA REPETIBLE CAPAZ DE EXPRESAR DICHO POLIPEPTIDO; SEGUIDO DEL CULTIVO DEL MICROORGANISMO TRANSFORMADO. EL MICROORGANISMO TRANSFORMADO PUEDE SER UNA CEPA E. COLI, BACILLUS SUBTILIS O SACHAROMYCES CEREVISIAE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIVIRAL.
ES515033A 1980-09-25 1982-08-16 "proceso para la produccion microbiana de interferon fibroblasto humano". Expired ES8306325A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19079980A 1980-09-25 1980-09-25
US29189281A 1981-08-11 1981-08-11

Publications (2)

Publication Number Publication Date
ES515033A0 ES515033A0 (es) 1983-06-01
ES8306325A1 true ES8306325A1 (es) 1983-06-01

Family

ID=26886463

Family Applications (3)

Application Number Title Priority Date Filing Date
ES505742A Granted ES505742A0 (es) 1980-09-25 1981-09-24 Proceso para la produccion microbiana de interferon fibro- blasto humano
ES515033A Expired ES8306325A1 (es) 1980-09-25 1982-08-16 "proceso para la produccion microbiana de interferon fibroblasto humano".
ES515032A Granted ES515032A0 (es) 1980-09-25 1982-08-16 "proceso para la produccion microbiana de interferon fibroblasto humano".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES505742A Granted ES505742A0 (es) 1980-09-25 1981-09-24 Proceso para la produccion microbiana de interferon fibro- blasto humano

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES515032A Granted ES515032A0 (es) 1980-09-25 1982-08-16 "proceso para la produccion microbiana de interferon fibroblasto humano".

Country Status (33)

Country Link
US (1) US5460811A (es)
EP (1) EP0048970A3 (es)
AT (1) AT380694B (es)
AU (1) AU582110B2 (es)
BR (1) BR8106137A (es)
CA (1) CA1341569C (es)
CH (2) CH656388A5 (es)
DD (3) DD209652A5 (es)
DE (1) DE3138096A1 (es)
DK (1) DK423381A (es)
ES (3) ES505742A0 (es)
FI (1) FI812993A7 (es)
FR (1) FR2490675B1 (es)
GB (1) GB2098996B (es)
GR (1) GR81946B (es)
HK (1) HK43686A (es)
IE (1) IE51679B1 (es)
IL (1) IL63916A0 (es)
IT (1) IT1139487B (es)
KE (1) KE3630A (es)
LU (1) LU83648A1 (es)
MC (1) MC1423A1 (es)
MT (1) MTP900B (es)
MY (1) MY8600634A (es)
NL (1) NL8104400A (es)
NO (1) NO813248L (es)
NZ (1) NZ198445A (es)
OA (1) OA06908A (es)
PL (1) PL233194A1 (es)
PT (1) PT73728B (es)
SE (1) SE8105657L (es)
YU (1) YU44835B (es)
ZW (1) ZW23981A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
DK170476B1 (da) * 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
AU575301B2 (en) * 1982-10-08 1988-07-28 Juridical Foundation, Japanese Foundation For Cancer Research Novel vector
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (es) * 1982-12-22 1984-10-02 Genentech Inc
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GB8414354D0 (en) * 1984-06-05 1984-07-11 Biogen Nv Purifying protein
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
US4680262A (en) * 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
EP0237019A3 (en) * 1986-03-14 1988-03-09 Toray Industries, Inc. Interferon conjugate and production thereof using recombinant gene
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US6713609B1 (en) 1996-07-16 2004-03-30 Genentech, Inc. Monoclonal antibodies to type I interferon receptor
JP3576819B2 (ja) 1997-07-30 2004-10-13 キヤノン株式会社 情報処理装置及び印刷制御方法並びに記憶媒体
US20030018174A1 (en) * 1997-10-06 2003-01-23 Genentech, Inc. Monoclonal antibodies to IFNAR2
EP1165835A2 (en) 1999-03-24 2002-01-02 Serono Genetics Institute S.A. GENOMIC SEQUENCE OF THE $i(PURH) GENE AND $i(PURH)-RELATED BIALLELIC MARKERS
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
JP4394350B2 (ja) * 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
RS20050501A (sr) * 2002-12-26 2007-08-03 Mountain View Pharmaceuticals Inc., Polimerni konjugati citokina,hemokina,faktora rasta, polipeptidnih hormona i njihovih antagonista sa očuvanom aktivnošću vezivanja receptora
GEP20084486B (en) 2002-12-26 2008-09-25 Mountain View Pharmaceuticals Polymer conjugates of interferon-beta with enhanced biological potency
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
JP2008543335A (ja) * 2005-06-22 2008-12-04 ジェネンテック・インコーポレーテッド Ｉｆｎａｒ２を標的とするための方法と組成物
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163600A (en) * 1977-11-08 1979-12-26 Genentech Inc Microbiological polypeptide expression method and means
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IN150740B (es) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
ZA803943B (en) * 1979-07-31 1981-06-24 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4418149A (en) * 1980-01-10 1983-11-29 President And Fellows Of Harvard College Fused hybrid gene
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DK170476B1 (da) * 1980-04-03 1995-09-11 Biogen Inc Rekombinant DNA-molekyle, uni-cellulær vært transformeret med mindst ét rekombinant DNA-molekyle, fremgangsmåde til transformering af en uni-cellulær vært, samt fremgangsmåder til fremstilling af et polpeptid, der udviser den immunologiske eller biologiske aktivitet af human beta-interferon
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes

Also Published As

Publication number Publication date
DK423381A (da) 1982-03-26
FI812993L (fi) 1982-03-26
NL8104400A (nl) 1982-04-16
BR8106137A (pt) 1982-06-15
ZW23981A1 (en) 1982-04-28
NZ198445A (en) 1984-05-31
ATA410381A (de) 1985-11-15
CH656388A5 (de) 1986-06-30
NO813248L (no) 1982-03-26
AT380694B (de) 1986-06-25
FR2490675A1 (fr) 1982-03-26
DD202085A5 (de) 1983-08-24
IE51679B1 (en) 1987-02-04
ES8306324A1 (es) 1983-06-01
US5460811A (en) 1995-10-24
ES515032A0 (es) 1983-06-01
AU7564981A (en) 1982-04-01
LU83648A1 (de) 1983-06-08
ES515033A0 (es) 1983-06-01
IT8124109A0 (it) 1981-09-23
EP0048970A2 (en) 1982-04-07
MC1423A1 (fr) 1982-10-18
PT73728B (en) 1984-05-08
AU582110B2 (en) 1989-03-16
OA06908A (fr) 1983-05-31
ES8307297A1 (es) 1983-07-01
GB2098996A (en) 1982-12-01
PT73728A (en) 1981-10-01
KE3630A (en) 1986-05-16
YU229781A (en) 1984-02-29
MY8600634A (en) 1986-12-31
IE812224L (en) 1982-03-25
FI812993A7 (fi) 1982-03-26
CH651309A5 (de) 1985-09-13
ES505742A0 (es) 1983-07-01
EP0048970A3 (en) 1982-08-18
YU44835B (en) 1991-04-30
GR81946B (es) 1984-12-12
IL63916A0 (en) 1981-12-31
SE8105657L (sv) 1982-03-26
DE3138096A1 (de) 1982-06-09
GB2098996B (en) 1985-02-06
CA1341569C (en) 2008-03-25
DD209477A5 (de) 1984-05-09
MTP900B (en) 1985-02-28
IT1139487B (it) 1986-09-24
PL233194A1 (en) 1983-07-18
DD209652A5 (de) 1984-05-16
HK43686A (en) 1986-06-20
FR2490675B1 (fr) 1985-11-15

Similar Documents

Publication Publication Date Title
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
ES8505724A1 (es) Procedimiento para la produccion de polipetidos mediante levadura.
MX9700818A (es) Produccion bacteriana de polipeptidos hidrofobicos.
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
GEP19960519B (en) Method of producing human luecocytary interferons
ES2063515T3 (es) Ifn-alfa o-glucosilados.
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
ES8304203A1 (es) Un procedimiento para la preparacion del complejo antibiotico a-4696.
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
ES420458A1 (es) Procedimiento para la preparacion de heptapeptidos.
MY102918A (en) Purified antineoplaston fractions and methods of treating neoplastic disease.
ES2006476A6 (es) Un procedimiento para obtener interleukin-2 humana
ES2109412T3 (es) (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
ES2068201T3 (es) Produccion de kalicreina.
AU1299588A (en) Polypeptides with activity against gram-positive and gram-negative bacteria
ES8700232A1 (es) Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES8300857A1 (es) Un procedimiento para la sintesis de insulina humana
ES8205416A1 (es) Un procedimiento para obtener el factor a2 del antibiotico a-16686.
ES2133819T3 (es) Procedimiento para preparar n-fosfonometilglicina.
ES8707554A1 (es) Procedimiento para preparar interferon-a recombinante
AU703179B2 (en) Recombinant canine gastric lipase and pharmaceutical compositions
ES8800722A1 (es) Metodo de produccion de un factor liberador de la hormona del crecimiento por la expresion en e. coli de polipeptidos hibridos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505